Title
Clinical and radiographic comparison of sybograf® and ostin® in treating periodontal intrabony defects
Authors
Kaushal Pati Tripathi1, Rohit Mishra2,*, Varsha Choubey2, Rajul Kaurav2, Anshul Gulati2 & Arohi Aglawe2
Affiliation
1Department of Periodontology, Faculty of Dental Sciences, IMS, Banaras Hindu University, Varanasi, Uttar Pradesh, India; 2Department of Periodontics & Implantology, Hitkarini Dental College and Hospital, Jabalpur, India; *Corresponding author
Kaushal Pati Tripathi - E-mail: jeevankaushal03@gmail.com
Rohit Mishra - E-mail: drrohitmishra7@gmail.com
Varsha Choubey - E-mail: varshac3008@gmail.com
Rajul Kaurav - E-mail: rajulkaurav1912@gmail.com
Anshul Gulati - E-mail: anshul478@gmail.com
Arohi Aglawe - E-mail: drarohiaglawe@gmail.com
Article Type
Research Article
Date
Received July 1, 2025; Revised July 31, 2025; Accepted July 31, 2025, Published July 31, 2025
Abstract
The capacity of Sybograf and Ostin to regenerate was compared in chronic periodontitis of three-wall vertical periodontitis defects. The material was randomly given for 30 patients and the clinical and radiographic assessments done at the baseline and after 3, 6, and 9 months. Sybograf (R) produced more effect of PPD reduction (4.2 mm, 72.4%) and RAL gain (4.3 mm, 32.58%) when compared to Ostin (R ) at 9 months. There was no gross discrepancy between the intergroup bone fill (Sybograf there was bone fill) and (Ostin there was bone fill) 33.1 per cent and 25.5 per cent, respectively. Sybograf 2 characteristic showed superior clinical results and both substrates were capable of regenerating bone efficiently.
Keywords
Generalized chronic periodontitis, infrabony defects, Sybograf ® and Ostin ®
Citation
Tripathi et al. Bioinformation 21(7): 1860-1864 (2025)
Edited by
Hiroj Bagde MDS, (PhD), PGDCR, PGDHHM, PGDL, PGDM
ISSN
0973-2063
Publisher
License
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
